New Jersey-based pharmaceutical manufacturer agrees to pay over $2 million to settle allegations
U.S. Attorney Philip Sellinger announced the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
•
Apr 11, 2024, 11:28 AM
•
Updated 300 days ago
Share:
More Stories
1:54
Icy conditions expected across the state, prep now for slippery commute
6h ago0:56
Women with genetic heart conditions reunited with doctors who saved her life
19h ago2:53
Fitness in 4: Total body tone
yesterday2:09
be Well: How to maintain good bone health
yesterday2:45
Fitness in 4: Upper & lower body workout
2ds ago2:55
be Well: How an AED can help save lives
2ds ago1:54
Icy conditions expected across the state, prep now for slippery commute
6h ago0:56
Women with genetic heart conditions reunited with doctors who saved her life
19h ago2:53
Fitness in 4: Total body tone
yesterday2:09
be Well: How to maintain good bone health
yesterday2:45
Fitness in 4: Upper & lower body workout
2ds ago2:55
be Well: How an AED can help save lives
2ds agoA drug manufacturer based in Somerset has agreed to pay $2.25 million to the federal government.
U.S. Attorney Philip Sellinger announced Wednesday that the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
Officials say a Drug Enforcement Administration investigation revealed that Novel Laboratories failed to account for large amounts of oxycodone, hydrocodone and temazepam over a two-year period beginning in 2019.
More from News 12
0:26
Runnemede man charged with murder after girlfriend's body found in refrigerator in forest
1:47
Decision to close Goetz Middle School in Jackson Township school expected today
1:18
All eastbound lanes reopen on Route 139 east of Jersey Avenue in Jersey City
0:25
Man faces murder charge in fatal shooting of 9-year-old Newark boy
0:27
Resident startles burglars who broke into Secaucus home
0:21
